Clinical Trial Update: An Open Label Study That Compares Varenicline to Transdermal Nicotine Patch for Smoking Cessation [Phase 3]

View source ↗

Summary

Pfizer-sponsored Phase 3 open-label trial compares varenicline to a transdermal nicotine patch for smoking cessation and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nicotine Dependence

Drugs mentioned

• Nicotine patch (nicotine patch)
• Varenicline (varenicline)

Snippet

Sponsor: Pfizer | Conditions: Smoking Cessation | Phase 3 | Status: COMPLETED